This review looked at 24 studies involving over 3,300 people to understand which factors help predict whether talk therapy will work well for conditions like ME/CFS, fibromyalgia, and IBS. Researchers found that how severe your symptoms are, whether you have depression or anxiety alongside your main condition, and the intensity of pain you experience can all affect how much therapy helps. This information could help doctors choose the right type of therapy for each person.
Why It Matters
For ME/CFS patients, this review provides evidence-based guidance on which factors predict psychotherapy success, helping clinicians personalize treatment plans and manage expectations. Understanding that depression and anxiety comorbidity affects outcomes is particularly relevant, as these conditions frequently co-occur with ME/CFS. This systematic evidence could improve treatment matching and outcomes in this challenging population.
Observed Findings
Comorbid depression and anxiety disorders predicted treatment outcomes across fibromyalgia, IBS, somatization disorder, hypochondriasis, medically unexplained symptoms, and dissociative seizures.
Pain intensity emerged as a primary predictor of treatment success in fibromyalgia and somatization.
Symptom severity at baseline predicted treatment outcomes across various functional disorders, with severe baseline severity affecting response.
Most psychotherapy interventions for functional disorders used CBT-based approaches (19/24 studies), with fewer using mindfulness, emotional-focused, psychodynamic, or operant behavioral methods.
Twenty-four eligible randomized controlled trials were identified from comprehensive search across PubMed, Web of Science, Embase, and Cochrane through November 2024.
Inferred Conclusions
Presence of comorbid mental health disorders, particularly depression and anxiety, is a robust predictor of psychotherapy outcomes across multiple functional disorders.
Baseline symptom severity and pain intensity are important prognostic indicators that clinicians should assess when predicting treatment response.
Clinicians can use these identified predictors to tailor psychotherapy trajectories and optimize treatment selection for individual patients with functional disorders.
Remaining Questions
Do comorbid depression and anxiety predict worse outcomes because they are genuinely prognostic, or because they complicate treatment engagement and compliance?
What This Study Does Not Prove
This review does not establish causation—only that certain factors are associated with better or worse outcomes. It does not prove that psychotherapy is equally effective for all ME/CFS patients, nor does it determine whether baseline severity actually limits improvement or simply reflects disease heterogeneity. The findings are primarily from CBT studies, so generalizability to other therapeutic approaches remains unclear.
How do non-CBT psychotherapies (psychodynamic, mindfulness-based, emotional-focused) compare in terms of predictors of success—do the same factors apply?
Can treatment approaches be modified or sequenced differently (e.g., addressing depression first) for patients with identified negative predictive factors to improve overall outcomes?
How stable are these predictive factors over time, and can early identification of poor-prognosis patients lead to treatment intensification or augmentation?